Nyxoah SA

XBRU:NYXH (Belgium)   Ordinary Shares
€ 4.59 (+0.44%) Dec 5
At Loss
P/B:
1.21
Market Cap:
€ 131.61M ($ 141.85M)
Enterprise V:
€ 72.08M ($ 77.68M)
Volume:
17.19K
Avg Vol (2M):
7.79K
Also Trade In:
Volume:
17.19K
At Loss
Avg Vol (2M):
7.79K

Business Description

Description
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Name Current Vs Industry Vs History
Cash-To-Debt 5.6
Equity-to-Asset 0.81
Debt-to-Equity 0.12
Debt-to-EBITDA -0.3
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.96
Distress
Grey
Safe
Beneish M-Score -1.58
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.59
9-Day RSI 35.86
14-Day RSI 34.32
6-1 Month Momentum % -26.6
12-1 Month Momentum % 20.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.55
Quick Ratio 5.43
Cash Ratio 5.01
Days Inventory 292
Days Sales Outstanding 142.09
Days Payable 565.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.3
Shareholder Yield % -0.39

Financials (Next Earnings Date:2024-03-22 Est.)

XBRU:NYXH's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Nyxoah SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 3.831
EPS (TTM) (€) -1.687
Beta 0.66
Volatility % 46.68
14-Day RSI 34.32
14-Day ATR (€) 0.18118
20-Day SMA (€) 4.734
12-1 Month Momentum % 20.26
52-Week Range (€) 4.5 - 9.26
Shares Outstanding (Mil) 28.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nyxoah SA Filings

Filing Date Document Date Form
No Filing Data

Nyxoah SA Stock Events

Event Date Price(€)
No Event Data

Nyxoah SA Frequently Asked Questions

What is Nyxoah SA(XBRU:NYXH)'s stock price today?
The current price of XBRU:NYXH is €4.59. The 52 week high of XBRU:NYXH is €9.26 and 52 week low is €4.50.
When is next earnings date of Nyxoah SA(XBRU:NYXH)?
The next earnings date of Nyxoah SA(XBRU:NYXH) is 2024-03-22 Est..
Does Nyxoah SA(XBRU:NYXH) pay dividends? If so, how much?
Nyxoah SA(XBRU:NYXH) does not pay dividend.

Press Release

Subject Date
No Press Release